Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma | 5 | 2021 | 16 | 1.220 |
Why?
|
| Retinal Neoplasms | 3 | 2021 | 11 | 1.020 |
Why?
|
| Spiral Ganglion | 3 | 2011 | 5 | 0.770 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 29 | 0.750 |
Why?
|
| Cannabinoids | 1 | 2021 | 56 | 0.720 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 86 | 0.720 |
Why?
|
| Cell Movement | 1 | 2021 | 571 | 0.590 |
Why?
|
| Neurons | 3 | 2014 | 1175 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 807 | 0.530 |
Why?
|
| Transport Vesicles | 1 | 2014 | 21 | 0.490 |
Why?
|
| Arrestins | 1 | 2014 | 27 | 0.490 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2014 | 40 | 0.480 |
Why?
|
| Endocytosis | 1 | 2014 | 113 | 0.460 |
Why?
|
| Nerve Growth Factors | 2 | 2011 | 33 | 0.400 |
Why?
|
| Presynaptic Terminals | 2 | 2011 | 53 | 0.390 |
Why?
|
| Synapses | 1 | 2011 | 180 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 360 | 0.320 |
Why?
|
| Endocannabinoids | 2 | 2021 | 39 | 0.300 |
Why?
|
| Ligands | 2 | 2021 | 349 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2007 | 517 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 259 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 502 | 0.210 |
Why?
|
| Mice | 7 | 2021 | 5913 | 0.210 |
Why?
|
| Mice, SCID | 2 | 2021 | 150 | 0.210 |
Why?
|
| Mice, Inbred ICR | 1 | 2021 | 40 | 0.190 |
Why?
|
| Mice, Inbred CBA | 3 | 2011 | 38 | 0.190 |
Why?
|
| Receptors, Cannabinoid | 1 | 2021 | 26 | 0.190 |
Why?
|
| Animals | 8 | 2021 | 15081 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 251 | 0.180 |
Why?
|
| Neoplasm Seeding | 1 | 2018 | 5 | 0.160 |
Why?
|
| Vitreous Body | 1 | 2018 | 11 | 0.160 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 16 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 122 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 40 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1198 | 0.130 |
Why?
|
| Glycerides | 1 | 2014 | 10 | 0.120 |
Why?
|
| Clathrin | 1 | 2014 | 21 | 0.120 |
Why?
|
| Arachidonic Acids | 1 | 2014 | 24 | 0.120 |
Why?
|
| Humans | 8 | 2021 | 37093 | 0.120 |
Why?
|
| Naphthalenes | 1 | 2014 | 38 | 0.120 |
Why?
|
| Benzoxazines | 1 | 2014 | 46 | 0.120 |
Why?
|
| Morpholines | 1 | 2014 | 69 | 0.120 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 153 | 0.120 |
Why?
|
| Science | 1 | 2013 | 18 | 0.120 |
Why?
|
| Apoptosis | 1 | 2021 | 1398 | 0.110 |
Why?
|
| Cultural Diversity | 1 | 2013 | 169 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 409 | 0.100 |
Why?
|
| Organ of Corti | 1 | 2011 | 2 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 803 | 0.090 |
Why?
|
| Hippocampus | 1 | 2014 | 561 | 0.090 |
Why?
|
| Imidazoles | 1 | 2011 | 126 | 0.090 |
Why?
|
| Piperazines | 1 | 2011 | 111 | 0.090 |
Why?
|
| Genomics | 1 | 2012 | 223 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 1742 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2018 | 1908 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 219 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 213 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1015 | 0.080 |
Why?
|
| Rats | 1 | 2014 | 3483 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 343 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2007 | 1518 | 0.070 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 12 | 0.060 |
Why?
|
| Male | 1 | 2021 | 20025 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 893 | 0.050 |
Why?
|
| Eye Enucleation | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 142 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 399 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 448 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 448 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 202 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 269 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 859 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 339 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2013 | 8 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2026 | 0.030 |
Why?
|
| Research | 1 | 2013 | 163 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 2012 | 1 | 0.030 |
Why?
|
| Communication | 1 | 2013 | 180 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 22 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2012 | 23 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 27 | 0.030 |
Why?
|
| Conjunctiva | 1 | 2011 | 6 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 118 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 132 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 267 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 187 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2011 | 112 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 474 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1378 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 730 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 864 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 587 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 1354 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 626 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 1095 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1609 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1371 | 0.020 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2004 | 5 | 0.010 |
Why?
|
| Cochlear Nerve | 1 | 2004 | 2 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 24 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2004 | 75 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 184 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 87 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 223 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 143 | 0.010 |
Why?
|
| Action Potentials | 1 | 2004 | 231 | 0.010 |
Why?
|